Every Form 4 that Interparfums, Inc. (IPAR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IPAR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IPAR filings page.
INTERPARFUMS INC (IPAR) director Veronique Gabai-Pinsky reported option-related transactions in company stock. On 2026-08-27 she exercised options to acquire 900 shares of common stock at an exercise price of $97.84 per share and on the same date sold 900 shares at $116.8586 per share. The filing also lists multiple remaining option-rights to buy common stock with exercise prices between $84.64 and $147.71 expiring between 2028 and 2031.
INTERPARFUMS INC director and CEO Jean Madar, through his personal holding company, reported an open-market sale of 20,000 shares of common stock at an average price of $91.018 per share on April 2, 2026.
After this transaction, the personal holding company’s indirect position stands at 7,066,341 shares of INTERPARFUMS INC common stock, while Madar also holds 10,500 shares directly. The filing shows a net reduction of 20,000 shares across his reported holdings.
Inter Parfums Inc. director François Heilbronn reported an option exercise and resulting share acquisition. On January 23, 2026, he exercised option rights to buy Inter Parfums common stock at an exercise price of $62.18 per share, converting derivative positions into 1,500 shares of common stock. Following this transaction, his directly held common stock position increased to 30,063 shares, up from 28,563 shares before the exercise.
The filing also lists multiple outstanding stock option grants, generally covering 300 shares each, with exercise prices such as $84.64, $97.84, $130.6, and $147.71, and expiration dates ranging from 2028 to 2031. These options represent potential future acquisitions of additional Inter Parfums shares if exercised.
Inter Parfums director Gilbert Harrison reported exercising stock options and acquiring common shares. On 01/22/2026, he exercised four "option-right to buy" grants, each for 375 shares of Inter Parfums common stock at an exercise price of $62.18 per share, for a total of 1,500 shares acquired. Following this transaction, he directly beneficially owned 3,050 shares of common stock.
The Form 4 also lists multiple remaining option awards held directly, each for 300 shares of common stock with exercise prices of $97.84, $147.71, $130.6, and $84.64, and stated vesting/exercisability dates ranging from 12/31/2023 through 12/31/2030 and expirations through 12/30/2031. Harrison is identified as a director of Inter Parfums, Inc.
Inter Parfums Inc. director Robert Bensoussan-Torres reported exercising stock options and increasing his direct shareholdings. On January 22, 2026, he exercised four “option-right to buy” awards for a total of 1,500 shares of common stock at an exercise price of $62.18 per share, bringing his directly held common stock to 12,500 shares. He also continues to hold multiple option-right-to-buy awards for 300 shares each at exercise prices including $97.84, $130.6 and $84.64, with expiration dates running from 2028 to 2031.
Inter Parfums Inc. director files an amended insider report that makes no changes to holdings and is solely to correct a personal address. The Form 4/A explains that it updates the reporting person's address from a London location to an address in Monaco, with all previously reported share and option positions unchanged.
The filing restates direct ownership of 11,000 shares of Inter Parfums common stock and a series of stock options to buy common shares at exercise prices including $62.18, $97.84, $147.71, $130.6, and $84.64 with expiration dates ranging from 2026 to 2031. The director is identified as filing individually, and the document is signed by an attorney-in-fact on the reporting person's behalf.
Interparfums Inc. director and Global Chief Commercial Officer Herve Bouillonnec reported exercising stock options and acquiring common shares. On 12/15/2025, he exercised options and acquired 1,500 shares of Interparfums common stock at $73.09 per share, leaving him with 1,500 shares beneficially owned directly after the transaction. The filing shows the corresponding option awards for 300-share tranches at a $73.09 exercise price being fully exercised and reduced to zero.
He continues to hold multiple remaining option awards to buy Interparfums common stock, including grants with exercise prices of $97.84, $147.71, and $130.6, with expiration dates ranging from late 2028 to late 2030, each covering between 800 and 1,000 underlying shares.
Inter Parfums Inc. insider Jean Madar, the company's CEO, director and a 10% owner, reported an equity transaction involving company stock. On December 15, 2025, his personal holding company acquired 25,000 shares of Inter Parfums common stock at $73.09 per share through the exercise of stock options. After this transaction, Madar's indirect ownership stood at 7,086,341 Inter Parfums shares held via his personal holding company.
Interparfums Inc. reported an insider transaction by a director, officer and 10% owner acting through a personal holding company. On 12/11/2025, the reporting person exercised stock options to acquire 25,000 shares of common stock at an exercise price of $73.09 per share and on the same day sold 25,000 shares at an average price of $83.2385 per share. After these trades, indirect beneficial ownership in Interparfums common stock remained at 6,846,064 shares, held through the personal holding company.
In connection with these transactions, a total of 25,000 option-rights to buy common stock with an exercise price of $73.09 and expiration on 12/30/2025 (five tranches of 5,000 options each) were exercised, leaving 0 of these derivative securities beneficially owned following the reported transactions.